Search
Searching Content indexed under Life Sciences, Biotechnology & Nanotechnology by Karen Taylor ordered by Published Date Descending.
Links to Result pages
 
1  
 
Title
Country
Organisation
Author
Date
1
2018: Evolutionary, Or Revolutionary?
In November 2017 we launched our report - ‘The future awakens: life sciences and health care predictions 2022' - which provides an overview of six predictions that we believe will transform health care.
UK
4 Apr 2018
2
The Future Awakens: Life Sciences And Health Care Predictions 2022
In 2014 we launched our first predictions report - Healthcare and life sciences predictions 2020: A bold future? It provided an intentionally positive and provocative view ...
Worldwide
20 Nov 2017
3
The Future Awakens - Life Sciences And Health Care Predictions 2022
The year is 2022. The quantified self is alive and well, digital technologies have transformed the culture of health care and new entrants have disrupted delivery models.
UK
16 Nov 2017
4
Keep Calm And Carry On: How Can The Healthcare And Life Sciences Industries Weather The Brexit Storm?
We have now had the best part of a week to absorb the momentous news that the UK has voted to leave the European Union.
UK
11 Jul 2016
5
What Would Brexit Mean For The Pharma Industry?
The Conservatives' 2015 election manifesto committed to hold a referendum by 2017 on whether or not the UK should stay in or leave the European Union.
UK
17 Feb 2016
6
The Challenge Of Compliance In Life Sciences: Moving From Cost To Value
Life sciences companies are having to address an increasing number of regulatory requirements which span multiple geographies, business activities and functions.
UK
26 Nov 2015
7
Pharmaceuticals Refocus
The increase in the value of mergers and acquisitions (M&A) in the life sciences and healthcare (LSHC) sector during 2014 is continuing in 2015
UK
18 Aug 2015
8
Doubling Down: The New Focus For Pharma
This week we thought it would be interesting to share insights on a topical issue from Deloitte's U.S. Center for Health Solutions. This "My Take" from the January 20th, 2015 Health Care Current written by Homi Kapadia, Vice Chairman, U.S Life Sciences Leader, Deloitte LLP, provides a view on the rise of "pure play" business strategies for life science companies
UK
2 Feb 2015
9
Is Healthcare And Life Sciences Procurement ‘Geared’ Up For Business Growth?
Deloitte’s 4th Annual Chief Procurement Officer global survey results, released last month, highlights the key challenges faced by procurement leaders.
UK
27 Jan 2015
10
Optimism In An Era Of Major Transformation For Global Life Sciences
As our final ‘Thought for the week’ of 2014, I thought I’d share with you the "My Take",first published in the US Center for Health Solutions December 9, 2014 Health Care Current.
UK
2 Jan 2015
11
A Bold Vision For Healthcare And Life Sciences In 2020
On Monday 17 November 2014 we launched our latest report, Healthcare and Life Sciences Predictions 2020, at the FT Global Pharmaceuticals and Biotechnology Conference 2014 in London.
UK
23 Nov 2014
12
Ebola - Better Understanding And Approach To R&D Needed To Tackle The Disease
My interest in finding out more about Ebola was sparked by colleagues writing for the US Center for Health Solutions.
UK
18 Nov 2014
13
Building Trust In The Collection And Use Of Real World Health Data
As our recent report Better care for frail older people identified: healthcare continues to face enormous cost and capacity challenges.
UK
7 Jul 2014
14
Improving Clinical Trials: A Virtual Solution To A Challenging Reality
Pharmaceutical companies face a very real and immediate challenge to achieve sustainable Research and Development models and produce affordable treatments.
UK
6 May 2014
15
Accessing Pharma Innovation – An Increasing Challenge For Patients?
Pharmaceutical companies fill their early stage research and development pipelines with more targeted niche products that address high unmet need.
UK
24 Mar 2014
Links to Result pages
 
1